Odysight.Ai Inc. Form 8-K Summary
Business Context and Reporting Period
Odysight.Ai Inc. (Nasdaq: ODYS), a Nevada corporation headquartered in Ramat Gan, Israel, filed this Current Report on Form 8-K on June 5, 2026. The filing discloses the entry into a Material Definitive Agreement regarding a new equity financing facility.
Key Financial Metrics and Transaction Details
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to the new Sales Agreement:
- Offering Capacity: Up to $20,000,000 in aggregate offering price of common stock.
- Sales Method: "At-the-market" offerings or privately negotiated transactions at prevailing market prices.
- Agent Commission: Up to 3.0% of gross proceeds from shares sold.
- Expense Reimbursement: Up to $75,000 for initial entry expenses and up to $7,500 per quarter for maintenance expenses.
- Underlying Registration: Shares issued pursuant to a Form S-3 shelf registration statement filed on January 30, 2026, and declared effective on February 6, 2026.
Material Changes
The material change disclosed is the execution of the Sales Agreement with Roth Capital Partners, LLC. This agreement provides the Company with a mechanism to raise capital by selling shares in the public market. The filing explicitly states that neither the Company nor the Agent is obligated to sell any shares, and no assurance is given regarding the timing, price, or volume of future sales.
Outlook, Risks, and Contingencies
Management Commentary: The Company retains discretion to issue placement notices specifying the number of shares, time periods, daily limits, and minimum prices. The Agent is required to use commercially reasonable efforts to sell shares consistent with normal trading practices.
Risks and Contingencies:
- Dilution Risk: Future sales of shares under this agreement will result in dilution to existing shareholders.
- Market Dependency: Sales are contingent on prevailing market prices and the Company's decision to issue placement notices.
- Indemnification: The Company has agreed to indemnify the Agent against certain liabilities under the Securities Act and the Exchange Act.
Investor Verification Checklist
- Verify the current share count and potential dilution impact of a full $20,000,000 issuance.
- Review the Company's recent cash position to assess the immediate necessity of this financing facility.
- Monitor future placement notices to determine actual sales volume and pricing.
- Confirm the status of the underlying Form S-3 registration statement (File No. 333-293080).
- Assess the impact of the 3.0% commission and expense reimbursements on net proceeds.